Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
George Amato, Nayaab S Khan & Rangan Maitra. (2019) A patent update on cannabinoid receptor 1 antagonists (2015-2018). Expert Opinion on Therapeutic Patents 29:4, pages 261-269.
Read now
Read now
Articles from other publishers (64)
Mohammad Bashashati & Ron Schey. 2023. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions. Handbook of Gastrointestinal Motility and Disorders of Gut-Brain Interactions
391
405
.
Rim Ben Necib, Claudia Manca, Sébastien Lacroix, Cyril Martin, Nicolas Flamand, Vincenzo Di Marzo & Cristoforo Silvestri. (2022) Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed. Frontiers in Immunology 13.
Crossref
Crossref
Saoirse Elizabeth O’Sullivan, Andrew S. Yates & Richard K. Porter. (2021) The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man. Molecules 26:20, pages 6178.
Crossref
Crossref
Estefanía Moreno, Milena Cavic & Enric I. Canela. (2021) Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease. International Journal of Molecular Sciences 22:7, pages 3661.
Crossref
Crossref
Paula Morales & Patricia H. Reggio. 2021. Cannabinoids and Neuropsychiatric Disorders. Cannabinoids and Neuropsychiatric Disorders
47
65
.
Allan Radaic & Daniel Martins-de-Souza. (2020) The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment. Nanomedicine: Nanotechnology, Biology and Medicine 28, pages 102222.
Crossref
Crossref
Johanna Escoubet, Mireille Kenigsberg, Murielle Derock, Veeranagouda Yaligara, Marie-Dominique Bock, Sandrine Roche, Florence Massey, Hélène de Foucauld, Charles Bettembourg, Anne Olivier, Antoine Berthemy, Joël Capdevielle, Richard Legoux, Eric Perret, Armelle Buzy, Pascale Chardenot, Valérie Destelle, Aurélie Leroy, Christophe Cahours, Sandrine Teixeira, Patrick Juvet, Pascal Gauthier, Michaël Leguet, Laurence Rocheteau-Beaujouan, Marie-Agnès Chatoux, Willy Deshayes, Margerie Clement, Mostafa Kabiri, Cécile Orsini, Vincent Mikol, Michel Didier & Jean-Claude Guillemot. (2020) ABHD11, a new diacylglycerol lipase involved in weight gain regulation. PLOS ONE 15:6, pages e0234780.
Crossref
Crossref
Alain Veilleux, Vincenzo Di Marzo & Cristoforo Silvestri. (2019) The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus. Current Diabetes Reports 19:11.
Crossref
Crossref
George Amato, Robert Wiethe, Amruta Manke, Vineetha Vasukuttan, Rodney Snyder, Scott Runyon & Rangan Maitra. (2019) Functionalized 6-(piperidin-1-yl)-8,9-diphenyl purines as inverse agonists of the CB1 receptor – SAR efforts towards selectivity and peripheralization. Bioorganic & Medicinal Chemistry 27:16, pages 3632-3649.
Crossref
Crossref
George Amato, Amruta Manke, Robert Wiethe, Vineetha Vasukuttan, Rodney Snyder, Yun Lan Yueh, Ann Decker, Scott Runyon & Rangan Maitra. (2019) Functionalized 6-(Piperidin-1-yl)-8,9-Diphenyl Purines as Peripherally Restricted Inverse Agonists of the CB1 Receptor. Journal of Medicinal Chemistry 62:13, pages 6330-6345.
Crossref
Crossref
Torsten Lowin, Matthias Schneider & Georg Pongratz. (2019) Joints for joints: cannabinoids in the treatment of rheumatoid arthritis. Current Opinion in Rheumatology 31:3, pages 271-278.
Crossref
Crossref
David O. Calligaro. 2019. Advanced Issue Resolution in Safety Pharmacology. Advanced Issue Resolution in Safety Pharmacology
287
302
.
Andrew J. Krentz, Christian Weyer & Marcus Hompesch. 2019. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease
3
35
.
Andrea Mastinu, Marika Premoli, Giulia Ferrari-Toninelli, Simone Tambaro, Giuseppina Maccarinelli, Maurizio Memo & Sara Anna Bonini. (2018) Cannabinoids in health and disease: pharmacological potential in metabolic syndrome and neuroinflammation. Hormone Molecular Biology and Clinical Investigation 36:2.
Crossref
Crossref
Jorge Manzanares, David Cabañero, Nagore Puente, María S. García-Gutiérrez, Pedro Grandes & Rafael Maldonado. (2018) Role of the endocannabinoid system in drug addiction. Biochemical Pharmacology 157, pages 108-121.
Crossref
Crossref
Robin van Eenige, Mario van der Stelt, Patrick C.N. Rensen & Sander Kooijman. (2018) Regulation of Adipose Tissue Metabolism by the Endocannabinoid System. Trends in Endocrinology & Metabolism 29:5, pages 326-337.
Crossref
Crossref
Ziqi Dong, Hui Gong, Yadan Chen, Hong Wu, Jun Wu, Yinghong Deng & Xinmao Song. (2018) LH-21, A Peripheral Cannabinoid Receptor 1 Antagonist, Exerts Favorable Metabolic Modulation Including Antihypertensive Effect in KKAy Mice by Regulating Inflammatory Cytokines and Adipokines on Adipose Tissue. Frontiers in Endocrinology 9.
Crossref
Crossref
Hélène Gilgenkrantz & Sophie Lotersztajn. (2018) Antagonistes du récepteur CB1 des cannabinoïdes et obésité. médecine/sciences 34:4, pages 296-299.
Crossref
Crossref
Mariana Schroeder, Yonat Drori, Yair J. Ben-Efraim & Alon Chen. (2018) Hypothalamic miR-219 regulates individual metabolic differences in response to diet-induced weight cycling. Molecular Metabolism 9, pages 176-186.
Crossref
Crossref
Wei Chen, Fengchun Shui, Cheng Liu, Xinbo Zhou, Wei Li, Zhibing Zheng, Wei Fu & Lili Wang. (2017) Novel Peripherally Restricted Cannabinoid 1 Receptor Selective Antagonist TXX-522 with Prominent Weight-Loss Efficacy in Diet Induced Obese Mice. Frontiers in Pharmacology 8.
Crossref
Crossref
Felix Schreiner, Merle Ackermann, Michael Michalik, Eva Hucklenbruch-Rother, Andras Bilkei-Gorzo, Ildiko Racz, Laura Bindila, Beat Lutz, Jörg Dötsch, Andreas Zimmer & Joachim Woelfle. (2017) Developmental programming of somatic growth, behavior and endocannabinoid metabolism by variation of early postnatal nutrition in a cross-fostering mouse model. PLOS ONE 12:8, pages e0182754.
Crossref
Crossref
Balázs Varga, Ferenc Kassai, György Szabó, Péter Kovács, János Fischer & István Gyertyán. (2017) Pharmacological comparison of traditional and non-traditional cannabinoid receptor 1 blockers in rodent models in vivo. Pharmacology Biochemistry and Behavior 159, pages 24-35.
Crossref
Crossref
Vincent Simon & Daniela Cota. (2017) MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future. European Journal of Endocrinology 176:6, pages R309-R324.
Crossref
Crossref
B. Chen & N. Hu. (2017) Rimonabant improves metabolic parameters partially attributed to restoration of high voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice. Brazilian Journal of Medical and Biological Research 50:6.
Crossref
Crossref
Herbert H. Seltzman, Rangan Maitra, Katharine Bortoff, Jay Henson, Patricia H. Reggio, Daniel Wesley & Joseph Tam. 2017. Cannabinoids and Their Receptors. Cannabinoids and Their Receptors
199
215
.
Natalia Schlabritz-Loutsevitch, Nadezhda German, Gary Ventolini, Eneko Larumbe & Jacques Samson. (2016) Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity. Medical Hypotheses 96, pages 35-38.
Crossref
Crossref
Bin Zhu, Jay M. Matthews, Mingde Xia, Shawn Black, Cailin Chen, Cuifen Hou, Yin Liang, Yuting Tang & Mark J. Macielag. (2016) Tetrahydropyrazolo[4,3-c]pyridine derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters 26:22, pages 5597-5601.
Crossref
Crossref
Jay M. Matthews, James J. McNally, Peter J. Connolly, Mingde Xia, Bin Zhu, Shawn Black, Cailin Chen, Cuifen Hou, Yin Liang, Yuting Tang & Mark J. Macielag. (2016) Tetrahydroindazole derivatives as potent and peripherally selective cannabinoid-1 (CB1) receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters 26:21, pages 5346-5349.
Crossref
Crossref
A.-L. Sberna, P. Degrace & B. Vergès. (2016) Système endocannabinoïde : effets sur le métabolisme glucidique, mais aussi lipidique. Médecine des Maladies Métaboliques 10:5, pages 407-414.
Crossref
Crossref
Maria Gomis-González, Arnau Busquets-Garcia, Carlos Matute, Rafael Maldonado, Susana Mato & Andrés Ozaita. (2016) Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. Genes 7:9, pages 56.
Crossref
Crossref
Praveen K. SinghRachel MarkwickFiona V. HowellGareth WilliamsPatrick Doherty. (2016) A novel live cell assay to measure diacylglycerol lipase α activity. Bioscience Reports 36:3.
Crossref
Crossref
Praveen K. Singh, Rachel Markwick, Leanne Lu, Fiona V. Howell, Gareth Williams & Patrick Doherty. (2016) Assay and Inhibition of the Purified Catalytic Domain of Diacylglycerol Lipase Beta. Biochemistry 55:19, pages 2713-2721.
Crossref
Crossref
Kindred K. Harris, Mohan Zopey & Theodore C. Friedman. (2016) Metabolic effects of smoking cessation. Nature Reviews Endocrinology 12:5, pages 299-308.
Crossref
Crossref
B Gatta-Cherifi & D Cota. (2015) New insights on the role of the endocannabinoid system in the regulation of energy balance. International Journal of Obesity 40:2, pages 210-219.
Crossref
Crossref
Dai Lu, Rachel Dopart & Debra A. Kendall. (2015) Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes. Cell Stress and Chaperones 21:1, pages 1-7.
Crossref
Crossref
Torsten Lowin & Rainer H. Straub. (2015) Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis. Arthritis Research & Therapy 17:1.
Crossref
Crossref
Wilfrid Mazier, Nicolas Saucisse, Blandine Gatta-Cherifi & Daniela Cota. (2015) The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease. Trends in Endocrinology & Metabolism 26:10, pages 524-537.
Crossref
Crossref
Tom J. J. Schirris, Tina Ritschel, G. Herma Renkema, Peter H. G. M. Willems, Jan A. M. Smeitink & Frans G. M. Russel. (2015) Mitochondrial ADP/ATP exchange inhibition: a novel off-target mechanism underlying ibipinabant-induced myotoxicity. Scientific Reports 5:1.
Crossref
Crossref
Ikuo Fujimori, Tomoya Yukawa, Taku Kamei, Yoshihisa Nakada, Nobuki Sakauchi, Masami Yamada, Yusuke Ohba, Maiko Takiguchi, Masako Kuno, Izumi Kamo, Hideyuki Nakagawa, Teruki Hamada, Tomoko Igari, Teruaki Okuda, Satoshi Yamamoto, Tetsuya Tsukamoto, Yuji Ishichi & Hiroyuki Ueno. (2015) Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor. Bioorganic & Medicinal Chemistry 23:15, pages 5000-5014.
Crossref
Crossref
Cristoforo Silvestri, Debora Paris, Andrea Martella, Dominique Melck, Irene Guadagnino, Mike Cawthorne, Andrea Motta & Vincenzo Di Marzo. (2015) Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. Journal of Hepatology 62:6, pages 1382-1390.
Crossref
Crossref
Rodrigo B. Mansur, Elisa Brietzke & Roger S. McIntyre. (2015) Is there a “metabolic-mood syndrome”? A review of the relationship between obesity and mood disorders. Neuroscience & Biobehavioral Reviews 52, pages 89-104.
Crossref
Crossref
David Baumeister, Luis M. Tojo & Derek K. Tracy. (2015) Legal highs: staying on top of the flood of novel psychoactive substances. Therapeutic Advances in Psychopharmacology 5:2, pages 97-132.
Crossref
Crossref
L H Vähätalo, S T Ruohonen, S Mäkelä, L Ailanen, A-M Penttinen, T Stormi, T Kauko, F Piscitelli, C Silvestri, E Savontaus & V Di Marzo. (2015) Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons. Nutrition & Diabetes 5:4, pages e151-e151.
Crossref
Crossref
Luca Costantino & Daniela Barlocco. (2015) New perspectives on the development of antiobesity drugs. Future Medicinal Chemistry 7:3, pages 315-336.
Crossref
Crossref
Blandine Gatta-Cherifi & Daniela Cota. 2015. Endocannabinoids. Endocannabinoids
367
391
.
Andrew J. Krentz, Lutz Heinemann & Marcus Hompesch. 2015. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development. Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development
3
43
.
M. M. Mahmoud, T. Olszewska, H. Liu, D. M. Shore, D. P. Hurst, P. H. Reggio, D. Lu & D. A. Kendall. (2014) (4-(Bis(4-Fluorophenyl)Methyl)Piperazin-1-yl)(Cyclohexyl)Methanone Hydrochloride (LDK1229): A New Cannabinoid CB1 Receptor Inverse Agonist from the Class of Benzhydryl Piperazine Analogs. Molecular Pharmacology 87:2, pages 197-206.
Crossref
Crossref
Sala Horowitz. (2014) The Medical Use of Marijuana: Issues and Indications. Alternative and Complementary Therapies 20:6, pages 320-327.
Crossref
Crossref
C. D’Addario, M.V. Micioni Di Bonaventura, M. Pucci, A. Romano, S. Gaetani, R. Ciccocioppo, C. Cifani & M. Maccarrone. (2014) Endocannabinoid signaling and food addiction. Neuroscience & Biobehavioral Reviews 47, pages 203-224.
Crossref
Crossref
Lirit N. Franks, Benjamin M. Ford, Nikhil R. Madadi, Narsimha R. Penthala, Peter A. Crooks & Paul L. Prather. (2014) Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs. European Journal of Pharmacology 737, pages 140-148.
Crossref
Crossref
Vincenzo Di Marzo & Luciano De Petrocellis. 2014. Cannabinoids. Cannabinoids
261
289
.
A. Chatzigeorgiou, E. Kandaraki, A. G. Papavassiliou & M. Koutsilieris. (2014) Peripheral targets in obesity treatment: a comprehensive update. Obesity Reviews 15:6, pages 487-503.
Crossref
Crossref
Gerry Jager & Renger F. Witkamp. (2014) The endocannabinoid system and appetite: relevance for food reward. Nutrition Research Reviews 27:1, pages 172-185.
Crossref
Crossref
Stefan Engeli, Anne-Christin Lehmann, Jana Kaminski, Verena Haas, Jürgen Janke, Alexander A. Zoerner, Friedrich C. Luft, Dimitrios Tsikas & Jens Jordan. (2014) Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects. Obesity 22:5, pages E70-E76.
Crossref
Crossref
Elżbieta Radziszewska, Monika Wolak & Ewa Bojanowska. (2014) Concurrent pharmacological modification of cannabinoid-1 and glucagon-like peptide-1 receptor activity affects feeding behavior and body weight in rats fed a free-choice, high-carbohydrate diet. Behavioural Pharmacology 25:1, pages 53-60.
Crossref
Crossref
Silvana Y. Romero-Zerbo & Francisco J. Bermúdez-Silva. (2014) Cannabinoids, eating behaviour, and energy homeostasis. Drug Testing and Analysis 6:1-2, pages 52-58.
Crossref
Crossref
Kjetil Berge, Fabiana Piscitelli, Nils Hoem, Cristoforo Silvestri, Ingo Meyer, Sebastiano Banni & Vincenzo Di Marzo. (2013) Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men. Lipids in Health and Disease 12:1.
Crossref
Crossref
S. Rossner. (2013) The obese uremic patient: a newcomer in the nephrology clinic?. Nephrology Dialysis Transplantation 28:suppl 4, pages iv117-iv119.
Crossref
Crossref
Maurizio Baldassarre, Ferdinando A. Giannone, Lucia Napoli, Alessandra Tovoli, Carmen S. Ricci, Manuel Tufoni & Paolo Caraceni. (2013) The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives. Liver International 33:9, pages 1298-1308.
Crossref
Crossref
Robert J. Chorvat. (2013) Peripherally restricted CB1 receptor blockers. Bioorganic & Medicinal Chemistry Letters 23:17, pages 4751-4760.
Crossref
Crossref
Andrea Mastinu, Marilena Pira, Gérard Aimè Pinna, Carla Pisu, Maria Antonietta Casu, Roberta Reali, Stefania Marcello, Gabriele Murineddu & Paolo Lazzari. (2013) NESS06SM reduces body weight with an improved profile relative to SR141716A. Pharmacological Research 74, pages 94-108.
Crossref
Crossref
E T Wargent, M S Zaibi, C Silvestri, D C Hislop, C J Stocker, C G Stott, G W Guy, M Duncan, V Di Marzo & M A Cawthorne. (2013) The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity. Nutrition & Diabetes 3:5, pages e68-e68.
Crossref
Crossref
Cristoforo Silvestri & Vincenzo Di Marzo. (2013) The Endocannabinoid System in Energy Homeostasis and the Etiopathology of Metabolic Disorders. Cell Metabolism 17:4, pages 475-490.
Crossref
Crossref
Petri Wiklund, Satu Pekkala & Sulin Cheng. (2013) Exercise, the endocannabinoid system and metabolic health. Journal of Sport and Health Science 2:1, pages 60-61.
Crossref
Crossref